| Dec 23, 2025 |
Dec 23, 2025 |
ANAPTYSBIO, INC
|
Director |
Sell |
20.0
|
-11,068
|
-17.48%
|
✗
|
$564.5K |
| Mar 25, 2025 |
Mar 27, 2025 |
ANAPTYSBIO, INC
|
Director |
Buy |
95.0
|
+11,068
|
23.94%
|
✗
|
$201.2K |
| Aug 12, 2024 |
Aug 13, 2024 |
Xeris Biopharma Holdings, Inc.
|
Director |
Buy |
83.8
|
+4,515
|
3.37%
|
✗
|
$10.1K |
| Aug 9, 2024 |
Aug 12, 2024 |
Xeris Biopharma Holdings, Inc.
|
Director |
Buy |
83.8
|
+4,285
|
3.31%
|
✗
|
$10.1K |
| May 10, 2024 |
May 10, 2024 |
Xeris Biopharma Holdings, Inc.
|
Director |
Buy |
86.3
|
+5,400
|
7.28%
|
✗
|
$10.3K |
| Mar 22, 2024 |
Mar 25, 2024 |
Design Therapeutics, Inc.
|
Director |
Buy |
95.0
|
+26,965
|
87.91%
|
✗
|
$99.7K |
| Mar 14, 2024 |
Mar 14, 2024 |
Xeris Biopharma Holdings, Inc.
|
Director |
Buy |
85.0
|
+4,500
|
6.46%
|
✗
|
$9.7K |
| Nov 16, 2023 |
Nov 17, 2023 |
Xeris Biopharma Holdings, Inc.
|
Director |
Buy |
90.0
|
+6,500
|
10.29%
|
✗
|
$9.8K |